Page 6 - Presentation

LEARNING OBJECTIVES

By participating in this educational session, health care

providers can expect to:

• Review the definition and risk assessment for patients with prostate

cancer who experience biochemical recurrence (BCR) following

radical prostatectomy

• Discuss the monitoring and management and recommendations

for patients who experience BCR, including local salvage therapy

and androgen deprivation therapy (ADT)

• Understand how new imaging modalities and treatment

intensification may affect the management of BCR